Healthcare startup Lapsi Health has announced that its newest innovation, Keikku, has received FDA Class II clearance, setting the stage for its US launch.
Designed for every HCP in healthcare, Keikku makes spotting potential issues faster and more accessible, thanks to the multiple data functions in its software architecture.
From streaming to sharing, to its wireless nature, the device empowers frontline clinicians without overburdening them with complex tech.
The company's founders are Jhonatan Bringas Dimitriades, MD (CEO), Diana van Stijn, MD PhD (Chief Medical Officer), Seamus Holohan (COO), and Rodrigo Alvez (CTO).
While the first-generation of Keikku focuses on sound-related data, upcoming updates will integrate many sensors for deeper diagnostic insights...
News articles remains the property of the source. Tellbrief is a news aggregator.
